MedPath

Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.

Completed
Conditions
Pleural Carcinomatosis
Interventions
Device: Study of the pleural cavity with a confocal laser endomicroscope.
Registration Number
NCT03805971
Lead Sponsor
University of Liege
Brief Summary

Probe based confocal laser endomicroscopy (pCLE) is a new optical endoscopic technique, generating fluorescent light emission from the tissue of interest and allowing in vivo live imaging at a cellular level ("optical biopsies"). It was first used in gastroenterology and came later to the light in pulmonary medicine and is still an experimental technique. In gastroenterology, this new investigational technique is used in Barret oesophagus, inflammatory bowel disease, pancreas cystic lesions... Nowadays, there are no data concerning usefulness of endomicroscopy in medical thoracoscopy. During thoracoscopy This new tool could help to target biopsies or help clinicians to do the right diagnosis early, allowing rapid therapeutic intervention (talc pleurodesis for example) . Furthermore, some details can be studied only during live imaging as microorganisms or bloodflows. The investigators performed an endomicroscopy to every patient needing a thoracoscopy (no matter the indication) and who agreed to participate. The pCLE features between malignant and benign pleura were compared in order to find specific criteria for malignant infiltration.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Every patient refered for a medical thoracoscopy and willing to participate.
Exclusion Criteria
  • < 18 ans

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patient aged more than 18 years admitted for thoracoscopyStudy of the pleural cavity with a confocal laser endomicroscope.Probe based confocal laser endomicroscopy (Mauna kea technologies) will be used, after intravenous fluorescein injection, for every patients admitted for medical thoracoscopy, to study the pleural cavity. Images will be compared with biopsies
Primary Outcome Measures
NameTimeMethod
Pleural Carcinomatosis Identification (Compared to Standard Biopsies). Qualitative Criteria.One day.

Eleven preselected criteria were assessed in their ability to distinguish benign from malignant pleura Qualitative variables are presented in this table

Pleural Carcinomatosis Identification (Compared to Standard Biopsies), Quantitative Criteria.One day

Eleven preselected pCLE criteria were assessed in their ability to distinguish benign from malignant pleura.

Quantitative criteria are presented in this table. Here is presented the vascular density.

Secondary Outcome Measures
NameTimeMethod
Quality of the pCLE AcquisitionOne day

The investigators performing the thoracoscopy had to score the pCLE acquisition. Three level of quality were used: Good, Acceptable, Low.

Trial Locations

Locations (1)

CHU de Liège

🇧🇪

Liège, Belgium

© Copyright 2025. All Rights Reserved by MedPath